TOP2A gene amplification and TOP2A deletion could be found in 35% and 5% of HER2-amplified breast cancer, respectively; however, only TOP2A gene deletion could be detected in 3% of HER2 nonamplified breast cancer [22]. The gene discussed is ERBB2; the disease is breast cancer.